Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with <scp>HIV</scp> aged 60 and older: Real‐world data from the Spanish <scp>RELATIVITY</scp> cohort

In this large multicentre real-world sub-study, LAI CAB + RPV maintained virological control and showed good tolerability in older people with HIV despite high multi-morbidity and long-term ART exposure. These findings extend the evidence from previous trials and support LAI CAB + RPV as a feasible option for geriatric HIV care. Longer follow-up will provide further insights into durability and quality-of-life benefits.

Authors

Institutions

Publication Details

Journal
HIV Medicine
Published
2025-10-21
DOI
https://doi.org/10.1111/hiv.70114
Citations
1
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
2.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish RELATIVITY cohort

Roberto Pedrero‐Tomé, Alberto Díaz-De Santiago, Juan José Soler, Adrián Rodríguez et al.
1 citations
HIV Medicine
HIV-related health complications and treatments
2.25
article

Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish RELATIVITY cohort

Roberto Pedrero‐Tomé, Alberto Díaz-De Santiago, Juan José Soler, Adrián Rodríguez, Marisa Montes, Francisco Fanjul, Rubén A. Cabo, Desiré Pérez, Laura Gisbert, Jesús Troya, Cristina Escrich, Carmen Hidalgo‐Tenorio, María Lagarde, Cristina Díez, Alberto Romero-Palacios, Daniel Rodríguez, Miguel Torralba, Eva Maria Luiz Ferreira, Sergio Padilla, María Antonia Sepúlveda, Marı́a José Galindo, Noelia Rúiz‐Alonso, Juan José Corte, María José Crussels
article en
1 citations

Abstract

In this large multicentre real-world sub-study, LAI CAB + RPV maintained virological control and showed good tolerability in older people with HIV despite high multi-morbidity and long-term ART exposure. These findings extend the evidence from previous trials and support LAI CAB + RPV as a feasible option for geriatric HIV care. Longer follow-up will provide further insights into durability and quality-of-life benefits.

HIV MedicineVol. 27(1)
Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital General De Segovia (ES), Hospital Universitario San Agustín (ES), Hospital Son Llatzer (ES), Hospital Universitario de Guadalajara (ES), Hospital Clínico Universitario de Valencia (ES), University Hospital Mútua de Terrassa (ES), Hospital Universitario 12 De Octubre (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Fundación Hospital de Jove (ES), Instituto de Investigación Marqués de Valdecilla (ES), Hospital Universitario de Burgos (ES), Hospital General Universitario de Elche (ES), Hospital Universitario Virgen de las Nieves (ES), Hospital Universitario Central de Asturias (ES), Hospital Clínico Universitario Lozano Blesa (ES), Hospital Universitario Puerto Real (ES), Hospital Universitario De Cabueñes (ES), Hospital Universitari de Tortosa Verge de la Cinta (ES), Hospital Universitario Son Espases (ES), Complejo Hospitalario Universitario de Toledo (ES), Hospital Universitario Infanta Leonor (ES), Hospital Universitario de Toledo (ES)
Openalex Percentile: Top 10%
HIV-related health complications and treatments
2.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.